Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.01.2024 | Case report

Lansoprazole/ticagrelor

Gastrointestinal bleeding, gum bleeding and lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Tian M-Y, et al. Comparison of ticagrelor Monotherapy and ticagrelor Plus aspirin Among patients With acute coronary syndrome Combined With High-Risk of Gastrointestinal Bleeding After Percutaneous Coronary Intervention : A Retrospective Cohort Study. Journal of Cardiovascular Pharmacology 82 : 327-332, No. 4, Oct 2023. Available from: URL: https://dx.doi.org/10.1097/FJC.0000000000001461 Tian M-Y, et al. Comparison of ticagrelor Monotherapy and ticagrelor Plus aspirin Among patients With acute coronary syndrome Combined With High-Risk of Gastrointestinal Bleeding After Percutaneous Coronary Intervention : A Retrospective Cohort Study. Journal of Cardiovascular Pharmacology 82 : 327-332, No. 4, Oct 2023. Available from: URL: https://​dx.​doi.​org/​10.​1097/​FJC.​0000000000001461​
Metadaten
Titel
Lansoprazole/ticagrelor
Gastrointestinal bleeding, gum bleeding and lack of efficacy
Publikationsdatum
01.01.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-52278-9

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Immune-globulin